Deregulated metabolism has been designated as an emerging hallmark of cancer in the last decade (93), which implies uncovering the biological effects of metabolic alterations induced by p53 and the underlying molecular mechanisms is of great importance for designing the optimized treatment strategies. The gene discussed is TP53; the disease is cancer.